KR900701309A - 액체 질소 및 재조합 DNA사람 α인터페론을 혼용하여 생식기우종을 치료하는 방법 - Google Patents
액체 질소 및 재조합 DNA사람 α인터페론을 혼용하여 생식기우종을 치료하는 방법Info
- Publication number
- KR900701309A KR900701309A KR1019900701395A KR900701395A KR900701309A KR 900701309 A KR900701309 A KR 900701309A KR 1019900701395 A KR1019900701395 A KR 1019900701395A KR 900701395 A KR900701395 A KR 900701395A KR 900701309 A KR900701309 A KR 900701309A
- Authority
- KR
- South Korea
- Prior art keywords
- interferon
- human
- infection
- administered
- liquid nitrogen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (9)
- 첨형 콘딜로마(Condylomata acuminata) 감염증의 각 병변에 유효량의 냉동외과용 제제를 투여란후, 각병변에 사람 α·인터페론의 유효량을 투여함을 특징으로 하여, 청형 콘딜로마 감염증의 치료를 요하는 환자를 치료하는 방법.
- 제1항에 있어서, 냉동외과용제제 (cryosurgical agent)가 액체 질소인 방법.
- 제1항 또는 제2항에 있어서, 사람 α인터페론이 재조합 사람 DNA 인터줴론 7·-2a 또는 r-2b인 방법
- 제1항 내지 제3항중 어느 한 항에 있어서, 사람 인터페론을 매주 3회 3주간 투여하는 방범.
- 제1항 내지 제4항중 어느 한 항에 있어서, 사람 α·인터페론을 병변내 주사로 투여하고 액체질소는 국소투여 하는 방법.
- 첨형 콘딜로마 감염증 환자에 사람 α·인터페론 및 냉동외과용제제를 투여하여 이 환자를 치료하는 혼용치료용 약제 제조를 위한 사람 α·인터페론의 용도.
- 냉동외과용 제제와 혼용으로 첨형 콘딜로마 감염증 환자를 치료하기 위한 사람 r인터궤론의 용도.
- 제6항 또는 제7항에 있어서. 사람 α인터페론이 재조합 사람 DNA 인터페론 α-2a 또는 α-2b인 용도.
- 사람 α인터페론 및 냉도외과용 제제를 첨형 콘딜로마 감염증 환자에 투여하여 치료하는 흔합 치료법에서 사용하기 위한 사람 α·인터페론을 포함함을 특징으로 하는, 약제학직 조성물.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/265,612 US4959210A (en) | 1988-11-01 | 1988-11-01 | Treatment of genital warts with a combination of liquid nitrogen and recombinant DNA human alpha interferon |
US265,612 | 1988-11-01 | ||
PCT/US1989/004766 WO1990004977A2 (en) | 1988-11-01 | 1989-10-30 | Treatment of genital warts with a combination of liquid nitrogen and recombinant dna human alpha interferon |
Publications (1)
Publication Number | Publication Date |
---|---|
KR900701309A true KR900701309A (ko) | 1990-12-01 |
Family
ID=23011173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019900701395A KR900701309A (ko) | 1988-11-01 | 1989-10-30 | 액체 질소 및 재조합 DNA사람 α인터페론을 혼용하여 생식기우종을 치료하는 방법 |
Country Status (12)
Country | Link |
---|---|
US (1) | US4959210A (ko) |
EP (2) | EP0369632A1 (ko) |
JP (1) | JPH03503766A (ko) |
KR (1) | KR900701309A (ko) |
AU (1) | AU636312B2 (ko) |
CA (1) | CA2001884A1 (ko) |
DK (1) | DK79591A (ko) |
IL (1) | IL92161A0 (ko) |
MY (1) | MY106603A (ko) |
PH (1) | PH26680A (ko) |
WO (1) | WO1990004977A2 (ko) |
ZA (1) | ZA898234B (ko) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5028422A (en) * | 1986-05-27 | 1991-07-02 | Schering Corporation | Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon |
US5165921A (en) * | 1989-01-23 | 1992-11-24 | National Geno Sciences, Inc. | Method for treating condyloma acuminatum with interferon |
US6001826A (en) * | 1989-12-21 | 1999-12-14 | Anormed, Inc. | Chemical compounds |
IL100415A0 (en) * | 1990-12-21 | 1992-09-06 | Schering Corp | Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases |
US6309662B1 (en) | 1999-09-23 | 2001-10-30 | Janet Buchanan | Use of anti-inflammatory drugs for treatment of dermatological conditions |
US7436227B2 (en) * | 2003-05-02 | 2008-10-14 | Silicon Laboratories Inc. | Dual loop architecture useful for a programmable clock source and clock multiplier applications |
GB2429207A (en) | 2004-02-02 | 2007-02-21 | Ambrx Inc | Modified human interferon polypeptides and their uses |
US20110218241A1 (en) * | 2010-03-06 | 2011-09-08 | Cacao Bio-Technologies, Llc | Antiviral epicatechins, epicatechin oligomers, or thiolated epicatechins from theobroma cacao for treatment of genital warts |
US20200038487A1 (en) | 2017-03-31 | 2020-02-06 | Accanis Biotech F&E Gmbh & Co Kg | Prevention and treatment of non-melanoma skin cancer (nmsc) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4503035B1 (en) * | 1978-11-24 | 1996-03-19 | Hoffmann La Roche | Protein purification process and product |
US4286690A (en) * | 1979-03-05 | 1981-09-01 | Commercial Management Corporation | Escape device |
JPS59175416A (ja) * | 1983-03-25 | 1984-10-04 | Sunstar Inc | 皮膚および粘膜の角化異常治療用外用剤 |
CA1321347C (en) * | 1986-11-10 | 1993-08-17 | David C. Munch | Human leukocyte interferon composition and skin treatment |
-
1988
- 1988-11-01 US US07/265,612 patent/US4959210A/en not_active Expired - Fee Related
-
1989
- 1989-10-30 AU AU45246/89A patent/AU636312B2/en not_active Ceased
- 1989-10-30 IL IL92161A patent/IL92161A0/xx unknown
- 1989-10-30 PH PH39444A patent/PH26680A/en unknown
- 1989-10-30 EP EP89311176A patent/EP0369632A1/en not_active Withdrawn
- 1989-10-30 WO PCT/US1989/004766 patent/WO1990004977A2/en not_active Application Discontinuation
- 1989-10-30 ZA ZA898234A patent/ZA898234B/xx unknown
- 1989-10-30 JP JP1511793A patent/JPH03503766A/ja active Pending
- 1989-10-30 EP EP89912698A patent/EP0445145A1/en active Pending
- 1989-10-30 KR KR1019900701395A patent/KR900701309A/ko not_active Application Discontinuation
- 1989-10-31 CA CA002001884A patent/CA2001884A1/en not_active Abandoned
- 1989-10-31 MY MYPI89001527A patent/MY106603A/en unknown
-
1991
- 1991-04-30 DK DK079591A patent/DK79591A/da unknown
Also Published As
Publication number | Publication date |
---|---|
WO1990004977A3 (en) | 1990-06-28 |
PH26680A (en) | 1992-09-15 |
EP0445145A1 (en) | 1991-09-11 |
AU636312B2 (en) | 1993-04-29 |
US4959210A (en) | 1990-09-25 |
AU4524689A (en) | 1990-05-28 |
CA2001884A1 (en) | 1990-05-01 |
EP0369632A1 (en) | 1990-05-23 |
JPH03503766A (ja) | 1991-08-22 |
DK79591A (da) | 1991-06-14 |
DK79591D0 (da) | 1991-04-30 |
ZA898234B (en) | 1990-07-25 |
WO1990004977A2 (en) | 1990-05-17 |
IL92161A0 (en) | 1990-07-12 |
MY106603A (en) | 1995-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9911076A (pt) | Uso de peg-ifn-alfa e ribavirina para o tratamento de hepatite c crÈnica | |
CO4970691A1 (es) | Terapia en combinacion para erradicar vhc-arn detectable en pacientes que padecen infeccion de hepatitis c cronica | |
WO2000037110A3 (en) | Ribavirin-pegylated interferon alfa induction hcv combination therapy | |
FI19991893A (fi) | Säädellysti budesonidia vapauttava oraalisesti annettava koostumus ja budesonidin käyttö | |
BR9507189A (pt) | Combinaçoes de proteinas tromboliticamente ativas e anticoagulantes e usos dos mesmos | |
BR0315573A (pt) | Método para tratar, prevenir, controlar e/ou modificar dor em um paciente e composição farmacêutica | |
KR900701309A (ko) | 액체 질소 및 재조합 DNA사람 α인터페론을 혼용하여 생식기우종을 치료하는 방법 | |
KR950007848A (ko) | (S)-(-)-α-에틸-2-옥소-1-피롤리딘아세트아미드를 사용한 불안치료방법 | |
KR910005858A (ko) | 지방산 요법 | |
AR022116A1 (es) | Terapia de combinacion para el vhc por induccion de ribavirina - interferon alfa | |
PT92995A (pt) | Metodo para o tratamento da disfuncao leucocita com gm-csf | |
KR960705578A (ko) | 경증 질환을 가진 b형 간염 보균자의 치료방법(method for treating hepatitis b carriers with minimal disease) | |
KR960013383A (ko) | 항혈전성 및 피브린용해성 치료제와 조합하여 사용되는 치료제로서의 폰 빌레브란트 인자(vWF)-함유 농축물의 용도 | |
ATE185274T1 (de) | Therapeutisches mittel gegen drohenden abortus | |
KR870010871A (ko) | 재조합 인체 알파 인터페론에 의한 기저세포 암종의 병소내적 치료방법 | |
ES2211996T3 (es) | Agentes de union a receptores de acido hialuronico y su uso para el tratamiento de tumores o de reestenosis. | |
ES2233101T3 (es) | Dosis unitaria de fgf-2 angiogenicamente efectiva y su utilizacion. | |
KR900701322A (ko) | 포도필린과 재조합 DNA인간 α인터페론의 배합물로 생식기 우췌를 치료하는 방법 | |
KR900701311A (ko) | 재조합 사람 α-인터페론을 병소내로 투여하여 편평세포 암을 치료하는 방법 | |
KR960701657A (ko) | 피부 상처 치료용 인자 XIII (Factor XIII for treatment of skin wounds) | |
KR910004186A (ko) | 제약학적 배합물 | |
BR0113115A (pt) | Tratamento de hepatite c com timosina, interferon e ribavirina | |
EA199800770A1 (ru) | Лекарственный препарат для терапевтического лечения вирусного гепатита | |
BR9812466A (pt) | Uso de ifn-alfa e amantadina para o tratamento da hepatite c crÈnica | |
Wagamon IV et al. | Interferons in the treatment of viral warts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |